NovaXS Biotech Corp. Company

The in-vitro fertilization process for women are not as desirable as the result. Within a cycle of 4 months, women are required to receive 148 total injections mixed with 4 different kinds of medications and 7 distinctive treatment schedules. Specifically, delivering viscous Progesterone Oil intramuscularly gives patients a nightmare. Telosis is the one-stop solution for IVF patients to simplify the self-administration process and improve treatment outcome.
Industry: Reproductive Health & Contraception
Headquarters: Berkeley, California, United States
Founded Date: 11-01-2021
Employees Number: 1-10
Funding Status: Seed
Investors Number: 6
Total Funding: $921,500
Last Funding Date: 2022-03-15
Last Funding Type: Seed

Visit Website
jxing@novaxs.co
Register and Claim Ownership